NCT00003891View on ClinicalTrials.gov

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 25, 1999

Primary Completion Date

June 8, 2001

Study Completion Date

September 22, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

lurtotecan liposome

Trial Locations (2)

V5Z 4E6

BC Cancer Agency, Vancouver

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

Sponsors

Collaborators (1)

Nexstar Pharmaceuticals
All Listed Sponsors
collaborator

Nexstar Pharmaceuticals

INDUSTRY

lead

NCIC Clinical Trials Group

NETWORK